Clinical trials: Strongyloidiasis
Strongyloides Stercoralis Infection, Strongyloidiasis
Treatment of Strongyloides Infection
The aim of this study is to evaluate the serologic response in patients with S. stercoralis infection after treatment with a regimen of two single doses of 200 µg/kg of ivermectin given 2 weeks apart versus a regimen of two…
- Trial name
- TSSI (NCT03605758)
- Testing
- Ivermectin
- Where
- United States
- Volunteers
- 51 people
- Sponsor
- Albert Einstein College of Medicine